Profile

New User

New to Graphy Publications? Create an account to get started today.

Registered Users

Have an account? Sign in now.

How to Cite | Author Information | Publication History
International Journal of Clinical Pharmacology & Pharmacotherapy Volume 1 (2016), Article ID 1:IJCPP-117, 5 pages
https://doi.org/10.15344/2456-3501/2016/117
Research Article
Oncological Patients Under Therapy and Potential Risks Associated to Interactions with Natural Products for Constipation Relieve

Nuno R. Jesus1, Cheila Batista1, Cátia M. Silva1, Tiago P.Silva1, Maria Luísa Costa1, Maria Helena Gervásio2, and Maria Graça Campos 1,3 *

1Observatory of Herb-Drug Interactions/ Faculty of Pharmacy (www.oipm.uc.pt), University of Coimbra, Heath Sciences Campus, Azinhaga de SantaComba, Coimbra Portugal
2PortugueseInstituteofOncologyof Coimbra Francisco Gentil (IPOFG. E.P.E.)Coimbra, Portugal
33Coimbra Chemistry Centre (CQC, FCTUnit 313) (FCTUC) Universityof Coimbra, Rua Larga, Coimbra, Portugal
Maria Graça Campos, Coimbra Chemistry Centre (CQC, FCTUnit 313) (FCTUC) Universityof Coimbra, Rua Larga, Coimbra, Portugal; E-mail: mgcampos@ff.uc.pt
04 May 2016; 19 September 2016; 21 September 2016
Jesus NR, Batista C, Silva CM, Silva TP, Costa ML, et al. (2016) Oncological Patients Under Therapy and Potential Risks Associated to Interactions with Natural Products for Constipation Relieve. Int J Clin Pharmacol Pharmacother 1: 117. doi: https://doi.org/10.15344/2456-3501/2016/117
© 2016 Jesus et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

References

  1. Kafeel H, Rukh R, Qamar H, Bawany J, Jamshed M, et al. (2014) Possibility of Drug-Drug Interaction in Prescription Dispensed by Community and Hospital Pharmacy. Pharmacol Pharm 5: 401-407 [CrossRef] [Google Scholar]
  2. Gagne JJ, Maio V, Rabinowitz C (2008) Prevalence and predictors of potential drug-drug interactions in Regione Emilia-Romagna, Italy. J Clin Pharm Ther 33: 141-151 [CrossRef] [Google Scholar] [PubMed]
  3. Doubova SV, Reyes-Morales H, Torres-Arreola LDP, Suárez-Ortega M (2007) Potential drug-drug and drug-disease interactions in prescriptions for ambulatory patients over 50 years of age in family medicine clinics in Mexico City. BMC Health Serv Res 7:147-155 [CrossRef] [Google Scholar] [PubMed]
  4. Elinav E, Pinsker G, Safadi R, Pappo O, Bromberg M, Anis E, et al. (2007) Association between consumption of Herbalife® nutritional supplements and acute hepatotoxicity. J Hepatol 47:514-520 [CrossRef] [Google Scholar] [PubMed]
  5. Piscitelli SC, Rodvold KA, Pai MP (2011) Drug Interaction in Infectious Disease (3rd edition), Berlin: Springerscience + Business Media; pp. 1-11
  6. Vonbach P, Dubied A, Krähenbühl S, Beer JH (2008) Prevalence of drugdrug interactions at hospital entry and during hospital stay of patients in internal medicine. Eur J Intern Med 19: 413-420 [CrossRef] [Google Scholar] [PubMed]
  7. Ben-Arye E, Samuels N, Goldstein LH, Mutafoglu K, Omran S, Schiff E, et al. (2016) Potential risks associated with traditional herbal medicine use in cancer care: A study of Middle Eastern oncology health care professionals. Cancer 122: 598-610 [CrossRef] [Google Scholar] [PubMed]
  8. SimónA (2013) Causas Secundárias de Obstipação. Revista da Ordem dos Farmacêuticos 108: 109-110
  9. Mendes E, Herdeiro MT, Pimentel F (2010) [The use of herbal medicine therapies by cancer patients]. Acta Med Port 23: 901-908 [Google Scholar] [PubMed]
  10. He SM, Yang AK, Li XT, Du YM, Zhou SF (2010) Effects of herbal products on the metabolism and transport of anticancer agents. Expert Opin Drug Metab Toxicol 6: 1195-1213 [CrossRef] [Google Scholar] [PubMed]
  11. Goey AK, Beijnen JH, Schellens JH (2014) Herb-drug interactions in oncology. Clin Pharmacol Ther 95: 354-355 [CrossRef] [Google Scholar] [PubMed]
  12. Cheng CW, Fan W, Ko SG, Song L, Bian ZX (2010) Evidence-based management of herb-drug interaction in cancer chemotherapy. Explore (NY) 6: 324-329 [CrossRef] [Google Scholar] [PubMed]
  13. Miranda N, Portugal C, Nogueira PJ, Farinha CS, Oliveira AL, et al. (2016) Doenças Oncológicas em números – 2015. Ministério da Saúde - Direção- Geral de Saúde. Lisboa
  14. Kirstein M (2009) Neoplastic Disorders and Their Treatment: General Principles. In: Koda-Kimble MA, Young LY, Alldredge BK, Corelli RL, Guglielmo BJ, Kradjan WA, Williams BR (Ed) Applied Therapeutics - The Clinical Use of Drugs (19th edition), Philadelphia: Lippincott Williams & Wilkins, 1-32 pp
  15. Morgan C, Nigam Y (2013) Naturally derived factors and their role in the promotion of angiogenesis for the healing of chronic wounds. Angiogenesis 16: 493-502 [CrossRef] [Google Scholar] [PubMed]
  16. Djuv A, Nilsen OG (2012) Aloe vera juice: IC50 and dual mechanistic inhibition of CYP3A4 and CYP2D6. Phytother Res 26: 445-451 [CrossRef] [Google Scholar] [PubMed]
  17. Alfredo V-O, Gabriel R-R, Luis C-G, David B-A (2008) Physicochemical properties of a fibrous fraction from chia (Salvia hispanica L.). LWT. Food Sci Technol 42: 168-173 [CrossRef] [Google Scholar]
  18. American Society of Health-System Pharmacists (2010) I. D. Tamoxifen
  19. Jaikang C, Niwatananun K, Narongchai P, Narongchai S (2011) Inhibitory effect of caffeic acid and its derivatives on human liver cytochrome P450 3A4 activity. J Med Plant Res 5: 3530-3536 [Google Scholar]
  20. Tavares AC, Zuzarte MR, Salgueiro LR (2010) Plantas Aromáticas e Medicinais - Escola Médica do Jardim Botânico de Coimbra (2nd edition), Coimbra: Imprensa da Universidade de Coimbra, Portugal, 229 p
  21. Fasinu PS, Bouic PJ, Rosenkranz B (2012) An overview of the evidence and mechanisms of herb-drug interactions. Front Pharmacol 3: 69 [CrossRef] [Google Scholar] [PubMed]
  22. Flower G, Fritz H, Balneaves LG, Verma S, Skidmore B, et al. (2014) Flax and Breast Cancer: A Systematic Review. Integr Cancer Ther 13: 181-192 [CrossRef] [Google Scholar] [PubMed]
  23. Gohil KJ, Patel JA (2007) Herb-drug interactions: A review and study based on assessment of clinical case reports in literature. Indian J Pharmacol 39: 129-139 [Google Scholar]
  24. Billinsky J, Maloney K, Krol E, Alcorn J (2012) A Comparison Between Lignans from Creosote Bush and Flaxseed and Their Potential to Inhibit Cytochrome P450 Enzyme Activity. In:, Prof. Omboon Vallisuta (Ed) Drug Discovery Research in Pharmacognosy [CrossRef] [Google Scholar]
  25. Costa ML, Rodrigues JA, Azevedo J, Vasconcelos V, Eiras E, et al. (2013) Toxic hepatitis associated with concurrent chemotherapy and microcystin contaminated supplement. In Proceedings of New England Science Symposium, Harvard
  26. Sun M, Sakakibara H, Ashida H, Danno G, Kanazawa K (2000) Cytochrome P4501A1-inhibitory action of antimutagenic anthraquinones in medicinal plants and the structure-activity relationship. Biosci Biotechnol Biochem 64: 1373-13178 [CrossRef] [Google Scholar] [PubMed]
  27. Tyagi LK, Singh M, Singh V, Singh N, Tyagi SN, et al. (2010) Herb-Drug Interactions: Emerging Threat and Their Management. Bot Res Int 3: 1-13
  28. Horta T, Butera AP, Henriques D, Leal S, Alves RJ (2007) Agentes antitumorais inibidores da angiogênese - Modelos farmacofóricos para inibidores da integrina a?ß 3. Rev Bras Cienc Farm 43:1-17
  29. Begonha R, Isabel A (2006) Citostáticos. In: Guimarães S, Moura D, Silva P, (Ed) Terapêutica Medicamentosa e suas Bases Farmacológicas (5th edition) Porto: Porto Editora; pp. 822–4
  30. INFARMED - Autoridade Nacional do Medicamento e Produtos de Saúde, IP (2010) Medicamentos antineoplásticos e imunomoduladores. In: Prontuário Terapêutico 9. 465-474 pp
  31. Cunha AP, Roque OR (2009) Compostos Quinónicos: Antraquinonas e Naftoquinonas. In: Cunha P (Ed) Farmacognosia e Fitoquímica(2th edition) Lisboa: Fundação Calouste Gulbenkian; 318-326 pp
  32. European Medicines Agency (2006) Community herbal monograph on Aloe barbadensis Miller and on Aloe (various species, mainly Aloe ferox Miller and its hybrids
  33. EFSA NDA Panel (EFSA Panel on Dietetic Products, Nutrition and Allergies) (2013) Scientific Opinion on the substantiation of a health claim related to hydroxyanthracene derivatives and improvement of bowel function pursuant to Article 13 (5) of Regulation (EC) No 1924/2006. EFSA Journal 2013 11: 1-12 [CrossRef] [Google Scholar]
  34. Højgaard L, Arffmann S, Jørgensen M, Krag E (1981) Tea consumption: a cause of constipation? Br Med J (Clin Res Ed) 282: 864 [CrossRef] [Google Scholar] [PubMed]
Best viewed in Mozilla Firefox, Google Chrome, Safari, Above IE 9.0 version
Privacy Policy | Copyright & Permissions
Copyright © 2013-2024 Graphy Publications, All Rights Reserved.